INOZYME PHARMA, INC. Shares Authorized
INOZYME PHARMA, INC. had Shares Authorized of 200.00 million shares as of 2025-03-31, per its 10-Q filed 2025-05-14.
Financial Statements › Balance Sheet › Equity › Stockholders' Equity, Number of Shares, Par Value and Other Disclosure › Common Stock, Number of Shares, Par Value and Other Disclosure
us-gaap:CommonStockSharesAuthorized · last filed 2025-05-14
- 2025-03-31: Common Stock, Shares Authorized 200.00M shares.
- 2024-12-31: Common Stock, Shares Authorized 200.00M shares.
- 2024-09-30: Common Stock, Shares Authorized 200.00M shares.
- 2024-06-30: Common Stock, Shares Authorized 200.00M shares.
| Period end | Common Stock, Shares Authorized |
|---|---|
| 2025-03-31 | 200.00M shares 10-Q · filed 2025-05-14 |
| 2024-12-31 | 200.00M shares 10-Q · filed 2025-05-14 |
| 2024-09-30 | 200.00M shares 10-Q · filed 2024-11-05 |
| 2024-06-30 | 200.00M shares 10-Q · filed 2024-08-06 |
| 2024-03-31 | 200.00M shares 10-Q · filed 2024-05-07 |
| 2023-12-31 | 200.00M shares 10-K · filed 2025-03-10 |
| 2023-09-30 | 200.00M shares 10-Q · filed 2023-11-07 |
| 2023-06-30 | 200.00M shares 10-Q · filed 2023-08-08 |
| 2023-03-31 | 200.00M shares 10-Q · filed 2023-05-09 |
| 2022-12-31 | 200.00M shares 10-K · filed 2024-03-12 |
| 2022-09-30 | 200.00M shares 10-Q · filed 2022-11-10 |
| 2022-06-30 | 200.00M shares 10-Q · filed 2022-08-15 |
| 2022-03-31 | 200.00M shares 10-Q · filed 2022-05-10 |
| 2021-12-31 | 200.00M shares 10-K · filed 2023-03-22 |
| 2021-09-30 | 200.00M shares 10-Q · filed 2021-11-09 |
| 2021-06-30 | 200.00M shares 10-Q · filed 2021-08-11 |
| 2021-03-31 | 200.00M shares 10-Q · filed 2021-05-12 |
| 2020-12-31 | 200.00M shares 10-K · filed 2022-03-15 |
| 2020-09-30 | 200.00M shares 10-Q · filed 2020-11-12 |
| 2020-07-28 | 200.00M shares 10-K · filed 2022-03-15 |
| 2020-06-30 | 129.00M shares 10-Q · filed 2020-09-03 |
| 2019-12-31 | 129.00M shares 10-K · filed 2021-03-25 |